Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/10/2025 ,inter alia, to consider and approve 1. To consider and approve the expansion plan of the Company's business operation through existing facility expansion and/or acquisition strategy, including: - Review of existing market opportunities and competitive landscape - Evaluation of expansion options, including capital expenditure requirements and potential returns arising therefrom - Discussion on acquisition targets, valuation, and integration plans aligned with the existing business operations - To evaluate the pros and cons of expanding existing facilities versus acquisition strategy and the long-term benefits arising therefrom of each of these options for the shareholders. 2. Any other business(s) with permission of the Chair, if any. You are requested to take the above information on your record. Thanking You.

pdf

Anlon Healthcare Ltd.

29 Sep 2025

125.10

-1.47%

SAST

Anlon Healthcare Ltd - 544497 - Closure of Trading Window

BSE India

Please Find Attached Herewith Intimation Relating To Closure Of Trading Window. Kindly Take Same on Your Records. Thank You

pdf

Anlon Healthcare Ltd.

29 Sep 2025

125.10

-1.47%

SAST

Anlon Healthcare Ltd - 544497 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Neomile Growth Fund Series I

pdf

Anlon Healthcare Ltd.

27 Sep 2025

125.10

-1.47%

Board Meeting

Anlon Healthcare Ltd - 544497 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

We have attached herewith outcome of Board Meeting held on Saturday, September 27, 2025. Kindly take the same on your record. Thank you.

pdf

Anlon Healthcare Ltd.

27 Sep 2025

125.10

-1.47%

SAST

Anlon Healthcare Ltd - 544497 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Neomile Growth Fund - Series I & Neomile Corporate Advisory Ltd

pdf

Anlon Healthcare Ltd.

24 Sep 2025

125.10

-1.47%

Board Meeting

Anlon Healthcare Ltd - 544497 - Board Meeting Intimation for Consider And Approve Proposal For Purchase …

BSE India

Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/09/2025 ,inter alia, to consider and approve 1. To consider and approve proposal for purchase of immovable property (Commercial Office) situated at Golden Crown, New 150 Feet Ring Road, Opp. IOC Petrol Pump, Near Parsana Chowk, Rajkot - 360005, Gujarat. 2. Any other business(s) with permission of Chair, if any. You are requested to take the above information on your record. Thanking You.

pdf

Anlon Healthcare Ltd.

23 Sep 2025

125.10

-1.47%

Company Update

Anlon Healthcare Ltd - 544497 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

We have attached herewith Intimation of Investor Meet as per Regulations 30 of SEBI (LODR) Regulations, 2015. Kindly take the same on your record. Thank you.

pdf

Anlon Healthcare Ltd.

22 Sep 2025

125.10

-1.47%

Company Update

Anlon Healthcare Ltd - 544497 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

We have attached herewith intimation of investor meet as per Reg. 30 of SEBI (LODR) Regulation, 2015. Kindly take the same on your record. Thank you.